Selective Degradation Permits a Feedback Loop Controlling Annexin A6 and Cholesterol Levels in Endolysosomes of NPC1 Mutant Cells.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
07 05 2020
Historique:
received: 08 04 2020
revised: 23 04 2020
accepted: 05 05 2020
entrez: 13 5 2020
pubmed: 13 5 2020
medline: 26 2 2021
Statut: epublish

Résumé

We recently identified elevated annexin A6 (AnxA6) protein levels in Niemann-Pick-type C1 (NPC1) mutant cells. In these cells, AnxA6 depletion rescued the cholesterol accumulation associated with NPC1 deficiency. Here, we demonstrate that elevated AnxA6 protein levels in NPC1 mutants or upon pharmacological NPC1 inhibition, using U18666A, were not due to upregulated AnxA6 mRNA expression, but caused by defects in AnxA6 protein degradation. Two KFERQ-motifs are believed to target AnxA6 to lysosomes for chaperone-mediated autophagy (CMA), and we hypothesized that the cholesterol accumulation in endolysosomes (LE/Lys) triggered by the NPC1 inhibition could interfere with the CMA pathway. Therefore, AnxA6 protein amounts and cholesterol levels in the LE/Lys (LE-Chol) compartment were analyzed in NPC1 mutant cells ectopically expressing lysosome-associated membrane protein 2A (Lamp2A), which is well known to induce the CMA pathway. Strikingly, AnxA6 protein amounts were strongly decreased and coincided with significantly reduced LE-Chol levels in NPC1 mutant cells upon Lamp2A overexpression. Therefore, these findings suggest Lamp2A-mediated restoration of CMA in NPC1 mutant cells to lower LE-Chol levels with concomitant lysosomal AnxA6 degradation. Collectively, we propose CMA to permit a feedback loop between AnxA6 and cholesterol levels in LE/Lys, encompassing a novel mechanism for regulating cholesterol homeostasis in NPC1 disease.

Identifiants

pubmed: 32392809
pii: cells9051152
doi: 10.3390/cells9051152
pmc: PMC7291204
pii:
doi:

Substances chimiques

Annexin A6 0
Intracellular Signaling Peptides and Proteins 0
Lysosomal-Associated Membrane Protein 2 0
NPC1 protein, human 0
Niemann-Pick C1 Protein 0
Green Fluorescent Proteins 147336-22-9
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Cell Sci. 2004 Jun 1;117(Pt 13):2631-9
pubmed: 15169834
Trends Cell Biol. 2012 Aug;22(8):407-17
pubmed: 22748206
J Cell Biol. 2009 Jun 29;185(7):1209-25
pubmed: 19564404
J Biol Chem. 2008 Oct 10;283(41):27871-80
pubmed: 18644787
Curr Opin Cell Biol. 2018 Aug;53:77-83
pubmed: 29960186
Elife. 2019 Oct 03;8:
pubmed: 31580258
Adv Exp Med Biol. 2017;981:351-385
pubmed: 29594868
Methods Enzymol. 2009;452:85-95
pubmed: 19200877
Autophagy. 2015;11(6):970-1
pubmed: 26000950
Nat Rev Mol Cell Biol. 2020 Feb;21(2):101-118
pubmed: 31768005
J Cell Mol Med. 2011 Feb;15(2):280-95
pubmed: 19929948
Nat Rev Mol Cell Biol. 2008 Feb;9(2):125-38
pubmed: 18216769
Biochim Biophys Acta. 2011 May;1813(5):935-47
pubmed: 20888375
Curr Opin Cell Biol. 2014 Aug;29:61-6
pubmed: 24813801
Cell Rep. 2014 May 8;7(3):883-97
pubmed: 24746815
Autophagy. 2012 May 1;8(5):719-30
pubmed: 22647656
Elife. 2015 Dec 08;4:
pubmed: 26646182
EMBO J. 2010 Nov 3;29(21):3607-20
pubmed: 20871593
J Colloid Interface Sci. 2010 Jun 15;346(2):436-41
pubmed: 20363475
Autophagy. 2013 Feb 1;9(2):234-5
pubmed: 23086309
Cell Rep. 2013 Dec 12;5(5):1302-15
pubmed: 24290752
Exp Cell Res. 2000 May 25;257(1):33-47
pubmed: 10854052
Traffic. 2020 May;21(5):354-363
pubmed: 32129938
Traffic. 2020 Jan;21(1):60-75
pubmed: 31808235
PLoS Biol. 2019 May 31;17(5):e3000301
pubmed: 31150375
Mol Biol Cell. 2011 Nov;22(21):4108-23
pubmed: 22039070
J Biol Chem. 2000 Oct 27;275(43):33806-13
pubmed: 10940299
J Biol Chem. 2010 Aug 20;285(34):26279-88
pubmed: 20554533
Cell. 2015 Jul 16;162(2):425-440
pubmed: 26186194
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):E705-14
pubmed: 22331875
J Biol Chem. 2017 Jun 23;292(25):10328-10346
pubmed: 28465352
Bio Protoc. 2017 Oct 5;7(19):
pubmed: 29082291
Cell Mol Life Sci. 2019 Oct 29;:
pubmed: 31664461
Dev Cell. 2011 Jan 18;20(1):131-9
pubmed: 21238931
Commun Integr Biol. 2012 Jul 1;5(4):308-11
pubmed: 23060949
Nat Rev Mol Cell Biol. 2018 Jun;19(6):365-381
pubmed: 29626215
J Biol Chem. 2000 Oct 27;275(43):33329-35
pubmed: 10938088
Nature. 2009 Apr 30;458(7242):1131-5
pubmed: 19339967
J Biol Chem. 2002 Aug 30;277(35):32187-94
pubmed: 12070178
PLoS One. 2007 Sep 05;2(9):e851
pubmed: 17786222
Nat Rev Mol Cell Biol. 2005 Jun;6(6):449-61
pubmed: 15928709
Autophagy. 2007 Nov-Dec;3(6):646-8
pubmed: 17921694
Nat Cell Biol. 2019 Feb;21(2):190-202
pubmed: 30598531
FASEB J. 2010 Aug;24(8):3052-65
pubmed: 20375270
Elife. 2016 Sep 24;5:
pubmed: 27664420
EMBO J. 2017 May 15;36(10):1412-1433
pubmed: 28377464
J Biol Chem. 2019 Feb 1;294(5):1706-1709
pubmed: 30710017
J Clin Invest. 2016 Nov 1;126(11):4140-4156
pubmed: 27701147
Nat Cell Biol. 2015 Jun;17(6):759-70
pubmed: 25961502
Dev Cell. 2016 Jun 6;37(5):473-83
pubmed: 27270042
J Cell Sci. 2012 Jan 1;125(Pt 1):92-107
pubmed: 22266906
Exp Cell Res. 2001 Sep 10;269(1):13-22
pubmed: 11525635
Semin Cell Dev Biol. 2018 Feb;74:21-28
pubmed: 28807884
Nat Commun. 2019 Aug 6;10(1):3521
pubmed: 31387993
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13087-92
pubmed: 25157141
Hum Mol Genet. 2012 Nov 15;21(22):4876-87
pubmed: 22872701
EMBO Mol Med. 2015 Jan 12;7(2):158-74
pubmed: 25586965
Nat Cell Biol. 2013 Jul;15(7):713-20
pubmed: 23817233
Nat Methods. 2013 Mar;10(3):259-64
pubmed: 23396283
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Mol Biol Cell. 2004 Jul;15(7):3132-45
pubmed: 15121881
Traffic. 2007 Nov;8(11):1568-89
pubmed: 17822395
J Biol Chem. 2018 Apr 13;293(15):5414-5424
pubmed: 29247007
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15287-92
pubmed: 18772377
Traffic. 2003 Apr;4(4):222-31
pubmed: 12694561
EMBO J. 2006 Sep 6;25(17):3921-33
pubmed: 16917501
Physiol Rev. 2002 Apr;82(2):331-71
pubmed: 11917092

Auteurs

Elsa Meneses-Salas (E)

Departament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036 Barcelona, Spain.
Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036-Barcelona, Spain.

Ana García-Melero (A)

Departament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036 Barcelona, Spain.
Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036-Barcelona, Spain.

Patricia Blanco-Muñoz (P)

Departament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036 Barcelona, Spain.
Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036-Barcelona, Spain.

Jaimy Jose (J)

School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney NSW 2006, Australia.

Marie-Sophie Brenner (MS)

School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney NSW 2006, Australia.

Albert Lu (A)

Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, United States.

Francesc Tebar (F)

Departament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036 Barcelona, Spain.
Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036-Barcelona, Spain.

Thomas Grewal (T)

School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney NSW 2006, Australia.

Carles Rentero (C)

Departament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036 Barcelona, Spain.
Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036-Barcelona, Spain.

Carlos Enrich (C)

Departament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036 Barcelona, Spain.
Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036-Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH